Prospective, randomised study of selective versus routine culture of vascular catheter tips: patient outcome, antibiotic use and laboratory workload - 02/08/11
, M. Guembe a, P. Martín-Rabadán a, P. Muñoz a, b, A. Fernández-Cruz a, E. Bouza a, bSummary |
In order to assess the value of vascular catheter tip culture in patients with negative blood cultures, all tip samples from hospitalised patients were prospectively randomised (1:1) to two different routines for processing catheters: culture of all tips (routine A) vs culture only of tips from patients with concomitant bacteraemia or fungaemia (routine B). Over a nine-month period, 426 catheters from 318 patients were randomly assigned to routine A and 429 catheters from 322 patients to routine B (n=40 patients). We compared the outcome and costs from both groups. No statistically significant differences were found with respect to demographic data, mortality, hospital stay or antimicrobial use. In non-bacteraemic/fungaemic cases (N=517), days on antimicrobial therapy after catheter withdrawal were significantly higher in patients from group A [10.0 days (interquartile range, IQR): 6.0–14.0] vs 8.0 days (IQR: 4.7–12.2), P=0.03], as was the number of daily defined doses (DDDs) of antimicrobials [10.8 DDDs (IQR: 2.4–26.9) vs 7.5 DDDs (IQR: 1.5–20.0), P=0.03]. Median antimicrobial cost per treated patient was significantly higher in group A: €222.30 (IQR: €20.30–€1,030.60) vs €109.10 (IQR: €10.90–€653.20), P=0.05. If all vascular catheter tips were processed according to routine B, the microbiology laboratory workload would decrease by 77% for the total number of catheters processed. Microbiology laboratories should not routinely culture catheter tips in patients without bacteraemia or fungaemia.
Le texte complet de cet article est disponible en PDF.Keywords : Bacteraemia, Catheter colonisation, Catheter-related bloodstream infection, Catheter tip culture, Central vascular catheters
Plan
| Presented orally at the 49th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC; Session: Innovative Strategies for Diagnosis and Prevention of Healthcare-Associated Infections), 14 September 2009, San Francisco, California, USA. |
Vol 77 - N° 4
P. 309-315 - avril 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
